ALXO
Alx Oncology Holdings Inc

1,246
Mkt Cap
$83.5M
Volume
30,071.00
52W High
$2.27
52W Low
$0.404
PE Ratio
-0.76
ALXO Fundamentals
Price
$1.53
Prev Close
$1.54
Open
$1.53
50D MA
$1.55
Beta
1.47
Avg. Volume
354,018.63
EPS (Annual)
-$2.58
P/B
1.84
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Receives Consensus Rating of "Moderate Buy" from Analysts
ALX Oncology Holdings Inc. (NASDAQ:ALXO - Get Free Report) has received an average rating of "Moderate Buy" from the seven ratings firms that are presently covering the company, MarketBeat.com...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
ALX Oncology (NASDAQ:ALXO) Upgraded by Wall Street Zen to Hold Rating
Wall Street Zen upgraded ALX Oncology from a "sell" rating to a "hold" rating in a report on Saturday...
MarketBeat·5d ago
News Placeholder
ALX Oncology (NASDAQ:ALXO) Stock Price Up 3.8% - Here's Why
ALX Oncology (NASDAQ:ALXO) Trading 3.8% Higher - Still a Buy...
MarketBeat·5d ago
News Placeholder
ALX Oncology (NASDAQ:ALXO) Earns Buy Rating from Analysts at Jefferies Financial Group
Jefferies Financial Group initiated coverage on ALX Oncology in a research report on Thursday. They set a "buy" rating and a $4.00 target price for the company...
MarketBeat·27d ago
News Placeholder
Cantor Fitzgerald Weighs in on ALX Oncology FY2025 Earnings
ALX Oncology Holdings Inc. (NASDAQ:ALXO - Free Report) - Analysts at Cantor Fitzgerald dropped their FY2025 earnings per share estimates for ALX Oncology in a report issued on Monday, November 10th...
MarketBeat·28d ago
News Placeholder
ALX Oncology (NASDAQ:ALXO) Issues Quarterly Earnings Results
ALX Oncology (NASDAQ:ALXO - Get Free Report) announced its quarterly earnings results on Friday. The company reported ($0.41) earnings per share (EPS) for the quarter, missing the consensus estimate...
MarketBeat·1mo ago
News Placeholder
Examining the Future: ALX Oncology Holdings's Earnings Outlook
read more...
Benzinga·1mo ago
News Placeholder
Is Alnylam Pharmaceuticals (ALNY) Outperforming Other Medical Stocks This Year?
Here is how Alnylam Pharmaceuticals (ALNY) and ALX Oncology Holdings Inc. (ALXO) have performed compared to their sector so far this year.
Zacks·2mo ago

Latest ALXO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.